Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid
2. 4-(1-imidazoylmethyl)cinnamic Acid
3. Oky 046
4. Oky-046
5. Ozagrel
6. Ozagrel, Monohydrochloride
7. Ozagrel, Monohydrochloride, (e)-isomer
8. Sodium Ozagrel
1. 78712-43-3
2. Ozagrel Hcl
3. Oky 046
4. 74003-18-2
5. Oky-046
6. (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylic Acid Hydrochloride
7. Chebi:31954
8. W222u960hs
9. Ozagrel (hydrochloride)
10. (e)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid;hydrochloride
11. Dsstox_cid_25506
12. Dsstox_rid_80920
13. Dsstox_gsid_45506
14. Chembl542549
15. (2e)-3-[4-(1h-imidazol-1-ylmethyl)phenyl]-2-propenoic Acid Hydrochloride
16. Smr000469164
17. Sr-01000597793
18. Unii-w222u960hs
19. (2e)-3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid Hydrochloride
20. (e)-3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid Hydrochloride
21. Oky046 Hydrochloride
22. Cpd000469164
23. Ncgc00016937-01
24. Cas-78712-43-3
25. Oky-046 Hcl
26. Schembl36182
27. Schembl36183
28. Ozagrel Hydrochloride- Bio-x
29. Mls001401435
30. Mls002222319
31. Dtxsid9045506
32. Hy-b0428b
33. Hms1571c19
34. Hms3412f19
35. Hms3676f19
36. Ozagrel Hydrochloride [mi]
37. Bcp09493
38. Tox21_110693
39. S2067
40. Akos015895402
41. Ozagrel Hydrochloride [who-dd]
42. Tox21_110693_1
43. Ccg-100969
44. Nc00219
45. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, Monohydrochloride, (e)-
46. Ncgc00025195-06
47. Bo164219
48. Ds-11967
49. Ls-14196
50. B2116
51. Cs-0013156
52. O0419
53. Sw197369-4
54. Sr-01000597793-1
55. Sr-01000597793-4
56. Q27114733
57. Trans-4-[(1-imidazolyl)methyl]cinnamic Acid Hydrochloride
58. (e)-3-[4-(imidazol-1-ylmethyl)phenyl]propenoic Acid Hydrochloride
59. (2e)-3-{4-[(1h-imidazol-1-yl)methyl]phenyl}prop-2-enoic Acid Hydrochloride
Molecular Weight | 264.71 g/mol |
---|---|
Molecular Formula | C13H13ClN2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 264.0665554 g/mol |
Monoisotopic Mass | 264.0665554 g/mol |
Topological Polar Surface Area | 55.1 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 283 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
Registration Number : 220MF10232
Registrant's Address : VIA F. BARACCA 19-24060 SAN PAOLO D'ARGON (BERGAMO) ITALY
Initial Date of Registration : 2008-11-17
Latest Date of Registration : 2018-06-26
Ozagrel hydrochloride monohydrate
Registrant Name : JDW Pharmaceutical Co., Ltd.
Registration Date : 2022-09-21
Registration Number : 20220921-209-J-1366
Manufacturer Name : Shiono Finesse, Ltd. (Fukui ...
Manufacturer Address : 156-1 Aza-hamawari, Yonozu 49, Mikuni-cho, Sakai, Fukui, Japan@19-48, Yoshino, Matsum...
About the Company : ERREGIERRE, a family company, was founded in 1974 and today is one of the leading Italian active pharmaceutical ingredients manufactures for human and veterinary use. In ERREGIE...
About the Company : Green Stone Swiss Co ., ltd.is a high-tech enterprise of pharmaceuticals and health ingredients, and provide customized products/OEM/ODM. We signed technical cooperation agreements...
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ozagrel Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ozagrel Hydrochloride, including repackagers and relabelers. The FDA regulates Ozagrel Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ozagrel Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ozagrel Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ozagrel Hydrochloride supplier is an individual or a company that provides Ozagrel Hydrochloride active pharmaceutical ingredient (API) or Ozagrel Hydrochloride finished formulations upon request. The Ozagrel Hydrochloride suppliers may include Ozagrel Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ozagrel Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ozagrel Hydrochloride Drug Master File in Japan (Ozagrel Hydrochloride JDMF) empowers Ozagrel Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ozagrel Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Ozagrel Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ozagrel Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ozagrel Hydrochloride Drug Master File in Korea (Ozagrel Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ozagrel Hydrochloride. The MFDS reviews the Ozagrel Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Ozagrel Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ozagrel Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ozagrel Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ozagrel Hydrochloride suppliers with KDMF on PharmaCompass.
Ozagrel Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ozagrel Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ozagrel Hydrochloride GMP manufacturer or Ozagrel Hydrochloride GMP API supplier for your needs.
A Ozagrel Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ozagrel Hydrochloride's compliance with Ozagrel Hydrochloride specifications and serves as a tool for batch-level quality control.
Ozagrel Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ozagrel Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ozagrel Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ozagrel Hydrochloride EP), Ozagrel Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ozagrel Hydrochloride USP).
LOOKING FOR A SUPPLIER?